METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORS
https://doi.org/10.17650/1994-4098-2017-13-2-27-32
Abstract
Introduction. In 70 % of patients with metastases of breast cancer in the ovaries, ovarian damage is detected simultaneously with the primary tumor, which affects the choice of tactics for diagnosis and treatment of such patients.
Materials and methods. The data of 30 patients with breast cancer with ovarian metastases and 35 patients with breast cancer without metastatic ovarian damage, which comprised the main and control groups. The groups were comparable in terms of main demographic and clinical features. Results. In the study of distant indicators, it is proved that the presence of metastases in the ovaries is a reliable adverse factor predicting a 3-year overall survival of patients older than 50 years who are in menopause and who received combined treatment.
Conclusions. Surgical treatment significantly increases the 3and 5-year overall survival of breast cancer patients with ovarian metastases (83.3 %), while the combined treatment of such patients does not significantly affect overall survival despite the high sensitivity of breast cancer to chemotherapy. This may be due to the fact that the patients included in the study who received the combined treatment had metastases to other organs (liver, lungs, bones).
About the Authors
S. N. Tadzhibov
I.M. Sechenov First Moscow State Medical University, Ministry Health of Russia
Russian Federation
Russian Federation
8 Build. 2, Trubetskaya St., Moscow 119991
S. B. Polikarpova
I.M. Sechenov First Moscow State Medical University, Ministry Health of Russia
Russian Federation
Russian Federation
8 Build. 2, Trubetskaya St., Moscow 119991
T. M. Kochoyan
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Russian Federation
Russian Federation
24 Kashirskoe Shosse, Moscow, 115478
N. I. Mehtieva
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Russian Federation
Russian Federation
24 Kashirskoe Shosse, Moscow, 115478
R. A. Kerimov
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Russian Federation
Russian Federation
24 Kashirskoe Shosse, Moscow, 115478
A. I. Berishvili
Research Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Russian Federation
Russian Federation
24 Kashirskoe Shosse, Moscow, 115478
References
1. Давыдов М.И. Злокачественные образования в России и странах СНГ в 2012 году / М.И. Давыдов, Е.М. Аксель. М.: Медицинское информационное агентство, 2012. [Davydov M.I. Malignant tumors in Russia and the CIS countries in 2012 / M.I. Davydov, E.M. Aksel. Moscow: Meditsinskoe informatsionnoe agentstvo, 2012. (In Russ.)].
2. Антошечкина Е.Т. Особенности клиники и факторы прогноза при злокачественных опухолях яичников у женщин молодого возраста. В кн.: Диагностика и лечебная тактика при ранних формах злокачественных опухолей яичников. М., 1984. С. 121–124. [Antoshechkina E.T. Characteristics of clinical manifestations and prognostic factors of ovarian tumors in young women. In: Diagnostics and treatment tactics in early forms of malignant ovarian tumors. Moscow, 1984. P. 121–124. (In Russ.)].
3. Alvarado-Cabrero I., Rodríguez-Gómez A., Castelan-Pedraza J., Valencia-Cedillo R. Metastatic ovarian tumors: a clinicopathologic study of 150 cases. Anal Quant Cytopathol Histpathol 2013 Oct;35(5):241–8. DOI: 10.1109/chicc.2006.4347343. PMID: 24282903.
4. Yada-Hashimoto N., Yamamoto T., Kamiura S. et al. Metastatic ovarian tumors: a review of 64 cases. Gynecol Oncol 2013;89(2):314–7. DOI: 10.1016/s0090–8258(03)00075–1. PMID: 12713997.
5. Sokalska A., Timmerman D., Testa A.C. et al. Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses. Ultrasound Obstet Gynecol 2009 Oct;34(4): 462–70. DOI: 10.1002/uog.6444. PMID: 19685552.
6. Sung-Jong Lee, Jeong-Hoon Bae, A-Won Lee, et al. Clinical Characteristics of Metastatic Tumors to the Ovaries. J Korean Med Sci 2009 Feb;24(1):114–119. DOI: 10.3346/jkms.2009.24.1.114. PMID: 19270823.
7. Kondi-Pafiti A., Kairi-Vasilatou E., Iavazzo C. et al. Metastatic neoplasms of the ovaries: a clinicopathological study of 97 cases. Arch Gynecol Obstet 2011;284(5):1283–8. DOI: 10.1007/s00404-011-1847-4. PMID: 21311903.
8. Guerriero S., Alcazar J. L., Pascual M. A. et al. Preoperative diagnosis of metastatic ovarian cancer is related to origin of primary tumor. Ultrasound Obstet Gynecol 2012 May;39(5):581–6. DOI: 10.1002/uog.10120. PMID: 21998039.
9. Кочоян Т. М. Эндохирургияв диагностике и лечении больных с опухолями органов грудной клетки, брюшной полости и забрюшинного пространства. Дис. … д-ра. мед. наук, 2011.
10. Адамян Л. В., Франченко Н. Д., Алексеева М. Л. Диагностическая значимость определения онкомаркеров – CA 125, CA 19–9 и РЭА в гинекологии. Метод. рекомендации. М., 1994. 56 с.
11. Терновой С. К., Насникова И. Ю., Морозов С. П., Маркина Н. Ю., Алексеева Е. С. Лучевая диагностика злокачественных опухолей яичников. Вестник рентгенологии и радиологии. 2009;4–6:47–57.
12. Ayhan A., Guvenal T., Salman M. C. et al. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol 2005 Aug;98(2):235–41. DOI: 10.1016/j.ygyno2005.05.028. PMID: 15982725.
Review
For citations:
Tadzhibov S.N., Polikarpova S.B., Kochoyan T.M., Mehtieva N.I., Kerimov R.A., Berishvili A.I. METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORS. Tumors of female reproductive system. 2017;13(2):27-32. (In Russ.) https://doi.org/10.17650/1994-4098-2017-13-2-27-32
Views:
6320
Email this article 